Journal Article
. 2021 Feb;().
doi: 10.1007/s00432-021-03525-6.

Associated factors and outcomes of delaying adjuvant chemotherapy in breast cancer by biologic subtypes: a National Cancer Database study

Prashanth Ashok Kumar 1 Shweta Paulraj 2 Dongliang Wang 3 Danning Huang 3 Abirami Sivapiragasam 4 
Affiliations
  • PMID: 33517468
  •     33 References

Abstract

Purpose: Several studies have evaluated the role of delayed initiation of adjuvant chemotherapy (AC) in breast cancer (BC), but the results have remained controversial and an optimal time has not been defined. Our aim was to determine the effect of time to starting AC from the date of surgery on survival of BC patients, based on estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) status, using data from the National Cancer Database (NCDB).

Methods: A total of 332,927 Stage I-III BC patients who received AC from 2010 to 2016 were analyzed. We included all ER, PR and HER2 statuses and excluded patients with stage 4 and stage 0 (DCIS) disease. The cohort was divided into five groups based on the time of initiating AC from the date of the most definitive surgery i.e., ≤ 30 days, 31-60 days, 61-90 days, 91-120 days and > 120 days. They were further divided into five subgroups based on the receptor status.

Results: Hazard ratio (HR) estimates and Kaplan-Meier (KM) analysis shows that starting AC by 31-60 days shows the best survival outcome in all the subtypes, except in hormone positive/HER2 negative BC in which 31-60 days and 61-90 days have similar outcomes.

Conclusions: After surgery for BC, it takes around 4-6 weeks to begin AC and delay in initiating the same leads to poor outcomes. Our results are particularly significant in triple-negative breast cancer (TNBC), similar to prior studies showing a benefit to starting AC as early as possible after surgery.

Keywords: Adjuvant chemotherapy; Breast cancer; Delay in adjuvant chemotherapy; National Cancer Database.

Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer.
Caroline Lohrisch, Charles Paltiel, +4 authors, Ivo A Olivotto.
J Clin Oncol, 2006 Oct 04; 24(30). PMID: 17015884
Advances in the systemic treatment of triple-negative breast cancer.
J M Lebert, R Lester, +2 authors, J McCarthy.
Curr Oncol, 2018 Jun 19; 25(Suppl 1). PMID: 29910657    Free PMC article.
Highly Cited. Review.
The relationship between time to initiation of adjuvant chemotherapy and survival in breast cancer: a systematic review and meta-analysis.
Michael J Raphael, James J Biagi, +3 authors, William J Mackillop.
Breast Cancer Res Treat, 2016 Sep 16; 160(1). PMID: 27632288
Systematic Review.
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG).
Lancet, 2005 May 17; 365(9472). PMID: 15894097
Highly Cited.
The National Cancer Data Base: a powerful initiative to improve cancer care in the United States.
Karl Y Bilimoria, Andrew K Stewart, David P Winchester, Clifford Y Ko.
Ann Surg Oncol, 2008 Jan 10; 15(3). PMID: 18183467    Free PMC article.
Highly Cited.
Risk factors for delay of adjuvant chemotherapy in non-metastatic breast cancer patients: A systematic review and meta-analysis involving 186982 patients.
Xiaofang He, Fen Ye, +4 authors, Xiaoming Xie.
PLoS One, 2017 Mar 17; 12(3). PMID: 28301555    Free PMC article.
Systematic Review.
Risk Factors and Preventions of Breast Cancer.
Yi-Sheng Sun, Zhao Zhao, +7 authors, Han-Ping Zhu.
Int J Biol Sci, 2017 Dec 07; 13(11). PMID: 29209143    Free PMC article.
Highly Cited. Review.
Effect of Surgery Type on Time to Adjuvant Chemotherapy and Impact of Delay on Breast Cancer Survival: A National Cancer Database Analysis.
Amanda R Kupstas, Tanya L Hoskin, +2 authors, Judy C Boughey.
Ann Surg Oncol, 2019 Jul 25; 26(10). PMID: 31332635
Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma.
Victor R Grann, Andrea B Troxel, +3 authors, Alfred I Neugut.
Cancer, 2005 Apr 22; 103(11). PMID: 15844176
Current treatment of early breast cancer: adjuvant and neoadjuvant therapy.
Elizabeth Miller, Hee Jin Lee, +3 authors, Bora Lim.
F1000Res, 2014 Nov 18; 3. PMID: 25400908    Free PMC article.
Review.
Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women.
Dawn L Hershman, Xiaoyan Wang, +3 authors, Alfred I Neugut.
Breast Cancer Res Treat, 2006 Apr 04; 99(3). PMID: 16583264
Time to Surgery and Breast Cancer Survival in the United States.
Richard J Bleicher, Karen Ruth, +8 authors, Brian L Egleston.
JAMA Oncol, 2015 Dec 15; 2(3). PMID: 26659430    Free PMC article.
Highly Cited.
Does timing of adjuvant chemotherapy influence the prognosis after early breast cancer? Results of the Danish Breast Cancer Cooperative Group (DBCG).
S Cold, M Düring, +2 authors, S Møller.
Br J Cancer, 2005 Sep 02; 93(6). PMID: 16136052    Free PMC article.
Cancer Statistics, 2017.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal.
CA Cancer J Clin, 2017 Jan 06; 67(1). PMID: 28055103
Highly Cited.
US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status.
Nadia Howlader, Sean F Altekruse, +4 authors, Kathleen A Cronin.
J Natl Cancer Inst, 2014 Apr 30; 106(5). PMID: 24777111    Free PMC article.
Highly Cited.
Effect of surgical removal on the growth and kinetics of residual tumor.
N Gunduz, B Fisher, E A Saffer.
Cancer Res, 1979 Oct 01; 39(10). PMID: 476622
Highly Cited.
Presence of a growth-stimulating factor in serum following primary tumor removal in mice.
B Fisher, N Gunduz, +2 authors, E Saffer.
Cancer Res, 1989 Apr 15; 49(8). PMID: 2702641
Highly Cited.
Pathological Characteristics of Triple-Negative Breast Cancer at Main Referral Teaching Hospital, April 2014 to April 2015, Tehran, Iran.
Alireza Abdollahi, Mehrnoosh Etemadi.
Int J Hematol Oncol Stem Cell Res, 2016 Dec 09; 10(4). PMID: 27928473    Free PMC article.
Clinical impact of delaying initiation of adjuvant chemotherapy in patients with breast cancer.
Debora de Melo Gagliato, Ana M Gonzalez-Angulo, +5 authors, Mariana Chavez-Macgregor.
J Clin Oncol, 2014 Jan 29; 32(8). PMID: 24470007    Free PMC article.
Triple Negative Breast Cancer - An Overview.
Kartik Aysola, Akshata Desai, +10 authors, Veena N Rao.
Hereditary Genet, 2013 Jan 01; 2013(Suppl 2). PMID: 25285241    Free PMC article.
Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes.
Xiaofeng Dai, Liangjian Xiang, Ting Li, Zhonghu Bai.
J Cancer, 2016 Jul 09; 7(10). PMID: 27390604    Free PMC article.
Highly Cited. Review.
HER2-positive breast cancer: new therapeutic frontiers and overcoming resistance.
Sonia Pernas, Sara M Tolaney.
Ther Adv Med Oncol, 2019 Mar 27; 11. PMID: 30911337    Free PMC article.
Highly Cited. Review.
Factors Associated With Delays in Chemotherapy Initiation Among Patients With Breast Cancer at a Comprehensive Cancer Center.
Katya Losk, Ines Vaz-Luis, +6 authors, Craig A Bunnell.
J Natl Compr Canc Netw, 2016 Dec 14; 14(12). PMID: 27956536
Current approaches in treatment of triple-negative breast cancer.
Hanan Ahmed Wahba, Hend Ahmed El-Hadaad.
Cancer Biol Med, 2015 Jul 16; 12(2). PMID: 26175926    Free PMC article.
Highly Cited. Review.
Endocrine Therapy for Early Breast Cancer: Updated Review.
Alexander Tremont, Jonathan Lu, John T Cole.
Ochsner J, 2017 Dec 13; 17(4). PMID: 29230126    Free PMC article.
Review.
Using the National Cancer Database for Outcomes Research: A Review.
Daniel J Boffa, Joshua E Rosen, +9 authors, David P Winchester.
JAMA Oncol, 2017 Feb 28; 3(12). PMID: 28241198
Highly Cited. Review.
Survival and time to initiation of adjuvant chemotherapy among breast cancer patients: a systematic review and meta-analysis.
Qiao-Hui Zhan, Jian-Qin Fu, +2 authors, Chuan Wang.
Oncotarget, 2018 Feb 09; 9(2). PMID: 29416807    Free PMC article.
Chemotherapy in early breast cancer: when, how and which one?
Marcus Schmidt.
Breast Care (Basel), 2014 Sep 02; 9(3). PMID: 25177256    Free PMC article.
Review.
Impact of timing of adjuvant chemotherapy initiation and completion after surgery on racial disparities in survival among women with breast cancer.
Z Z Nurgalieva, L Franzini, +3 authors, X L Du.
Med Oncol, 2013 Jan 08; 30(1). PMID: 23292872
Delayed Initiation of Adjuvant Chemotherapy Among Patients With Breast Cancer.
Mariana Chavez-MacGregor, Christina A Clarke, Daphne Y Lichtensztajn, Sharon H Giordano.
JAMA Oncol, 2015 Dec 15; 2(3). PMID: 26659132    Free PMC article.
Highly Cited.
Review of Colorectal Studies Using the National Cancer Database.
Katherine A Kelley, V Liana Tsikitis.
Clin Colon Rectal Surg, 2019 Jan 17; 32(1). PMID: 30647548    Free PMC article.
Review.
Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients.
Lisa K Dunnwald, Mary Anne Rossing, Christopher I Li.
Breast Cancer Res, 2007 Jan 24; 9(1). PMID: 17239243    Free PMC article.
Highly Cited.
Targeted therapeutic options and future perspectives for HER2-positive breast cancer.
Jiani Wang, Binghe Xu.
Signal Transduct Target Ther, 2019 Oct 23; 4. PMID: 31637013    Free PMC article.
Review.